Document:

Negotiated Settlement Agreement btwn. Reliant Pharmaceuticals & Keith Rotenberg

 Exhibit 10.18 
 EXECUTION COPY 
  
 NEGOTIATED SETTLEMENT AGREEMENT, RELEASE, 
 AND COVENANT NOT TO SUE 
  
 FOR AND IN CONSIDERATION of the mutual promises, covenants, and agreements made in this
agreement (this “Agreement”) by and between KEITH ROTENBERG, PH.D. (“Employee”, a term which includes EMPLOYEE himself, EMPLOYEE’s spouse, and all assigns, heirs, and successors in interest) and RELIANT
PHARMACEUTICALS, INC. (“Reliant”, a term which for the purposes of this Agreement includes RELIANT, any and all parent, subsidiary, and affiliate corporations), the parties agree as follows: 
  
 1. Termination of Employment 
  
 EMPLOYEE has agreed to voluntarily resign his employment with RELIANT effective as of March
31, 2005 (“Termination Date”), whereupon all benefits and privileges related thereto will cease, except as set forth herein. 
  
 2. No Admissions 
  
 RELIANT and EMPLOYEE agree that the entry of the parties into this Agreement, and the agreements contained herein, are not and shall not be construed to be an admission of liability on the part of any party hereto or
any parties hereby released or held harmless. 
  
 3. Adequacy of
Consideration 
  
 The parties agree that RELIANT has no obligation to
EMPLOYEE to make the payments or arrangements set forth herein independent of this Agreement. The parties further acknowledge the adequacy of the “additional consideration” provided herein by each to the other, that this is a legally
binding document, and that they intend to comply with and be faithful to its terms. EMPLOYEE acknowledges that he has received payment for all salary, accrued but unused vacation and reimbursement for all reimbursable business expenses accrued
through the TERMINATION DATE and except for the payments under this Agreement, or benefits in which he is vested under RELIANT’s employee benefit plans, and that he has received all amounts to which he is otherwise entitled. 
  
 4. Payments to EMPLOYEE 
  
 In partial consideration for the promises of EMPLOYEE set forth herein, RELIANT to pay
EMPLOYEE the amounts set forth in Sections 4(a) and 4(b) below on the terms described in this Section 4: 
  

	 	a.	One Hundred Fourteen Thousand Five Hundred Eighty Three Dollars and No Cents ($114,583.00) to be paid in ten (10) equal installments of Eleven Thousand Four Hundred Fifty Eight
Dollars and 30/100 beginning with the second regularly pay period following the Termination Date. 

  

					
	Initials:         	 	1	 	Initials:         

	 	b.	An amount not to exceed Fifty Thousand Dollars and No Cents ($50,000.00) to be determined by the Compensation Committee of the Board of Directors of Reliant in its discretion
following input from senior management of Reliant and based on certain product related regulatory initiatives for which Employee was responsible during his employment with RELIANT and EMPLOYEE’S compliance with Section 11 below, to be paid (if
at all) at such time as bonuses for 2005 are paid to members of RELIANT’S senior management (but no later than March 15, 2006); provided that the payment described in this Section 2(c) shall be subject to the mandatory prepayment terms of that
certain Secured Promissory Note dated as of February 28, 2001 (as amended from time to time, the “83(b) Note”) made by EMPLOYEE in favor of RELIANT in the original principal amount of $200,000. 

  

	 	c.	The payments made pursuant to this Section 4 shall be (i) reduced by statutorily required deductions and (ii) made in accordance with RELIANT’s normal payroll practices.

  

	 	d.	RELIANT will make the above-stated payments to EMPLOYEE notwithstanding any set-off agreements which may have previously existed between RELIANT and EMPLOYEE and regardless of
whether he obtains any employment or income from any other source after the Termination Date. 

  

	 	e.	The payments made pursuant to this Section 4 shall not be matched by RELIANT or otherwise considered compensation to EMPLOYEE for purposes of RELIANT’s 401(k) or other benefit
plans. 

  

	 	f.	Other than as set forth herein, RELIANT is not obligated to pay EMPLOYEE any other compensation. 

  

	 	g.	RELIANT shall not be obligated to make any of the payments set forth herein if EMPLOYEE breaches this Agreement in any material way or revokes it pursuant to Section 28 herein. If
EMPLOYEE breaches the provisions of Sections 6 or 7 of this Agreement or the sections of the Employment Agreement (as defined below) that are listed in Section 24 hereof, he shall be obligated to repay RELIANT all amounts paid under this Section 4,
other than $100 thereof. 

  
 5. Other Benefits; Modification
of 83(b) Note 
  
 In further consideration for the promises of EMPLOYEE
set forth herein, RELIANT agrees to: 
  

	 	a.	 pay the premiums applicable to EMPLOYEE and/or his dependents pursuant to the 

  

					
	Initials:         	 	2	 	Initials:         

	 	 
Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) to the extent that EMPLOYEE and/or his dependents elect to continue
coverage under RELIANT’S group health or dental plans as available under COBRA. Such coverage shall be subject to the terms of the applicable policies that RELIANT may have in place from time to time for similarly situated employees.
RELIANT’s obligations to pay such premiums shall expire on the earlier of August 31, 2005 or the date EMPLOYEE and/or his dependents become covered under any other health plan or policy, whether or not Employee and/or his dependent’s
rights to continue coverage under COBRA have ceased. 

  

	 	b.	All of EMPLOYEE’S options shall continue to be governed by the Reliant Pharmaceutical, LLC Equity Incentive Plan originally adopted as of July 6, 2000 (as amended) and the
agreements pursuant to which such options were granted. In accordance with such Plan and agreements all of EMPLOYEE’S unvested options shall terminate effective as of the Termination Date. 

  

	 	c.	Nothing in this Agreement is intended to accelerate, alter or reduce any other vested or accrued benefits (if any) to which EMPLOYEE may be entitled under RELIANT’s 401(k)
Plan. 

  

	 	d.	In the event that EMPLOYEE breaches any of the provisions of this Agreement, then RELIANT shall have no further obligation to make the premium payments under Section 5(a), and all
vested and unexercised options then held EMPLOYEE shall automatically terminate and no longer be exercisable. 

  

	 	e.	Modify EMPLOYEE’S 83(b) Note pursuant to the First Amendment to Secured Promissory Note substantially in the form attached hereto as Exhibit A. 

 

	 	f.	Reliant will not oppose EMPLOYEE’S efforts to obtain unemployment benefits so long as EMPLOYEE is in compliance with the terms of this Agreement and his other obligations to
RELIANT; provided that the foregoing shall in no way prevent RELIANT from responding truthfully to inquiries from or investigations by governmental authorities with respect to EMPLOYEE’s application for such unemployment (or similar) benefits.

  
 6. EMPLOYEE’S Full Release of All Claims

  
 In consideration for the undertakings and promises of RELIANT set forth
in this Agreement, EMPLOYEE unconditionally releases, discharges, and holds harmless RELIANT, its officers, directors, shareholders, employees, agents, attorneys, suppliers and contractors (herein collectively referred to as “RELEASEES”),
from each and every claim, cause of action, right, liability or demand of any kind and nature, and from any claims which may be derived therefrom (collectively referred to as “claims”), that EMPLOYEE had, has, or might claim to have
against RELEASEES at the time EMPLOYEE executes this Agreement, including but not limited to any 
  

					
	Initials:         	 	3	 	Initials:         

 and all claims: 
  

	 	a.	arising from EMPLOYEE’s employment, pay, bonuses, commissions, vacation, sick leave, stock options, or any other EMPLOYEE benefits, and other terms and conditions of employment
or employment practices of RELIANT; 

  

	 	b.	relating to the termination of EMPLOYEE’s employment with RELIANT, the surrounding circumstances thereof, or any communications about the termination of EMPLOYEE’s
employment; 

  

	 	c.	relating to payment of any attorney’s fees for EMPLOYEE; 

  

	 	d.	based on discrimination on the basis of race, color, religion, sex, national origin, handicap, disability, age or any other category protected by law under Title VII of the Civil
Rights Act of 1964, the Civil Rights Act of 1991, Executive Order 11246, the Equal Pay Act, the Americans With Disabilities Act, the Rehabilitation Act of 1973, the Age Discrimination in Employment Act of 1967, the Older Workers Benefits Protection
Act, COBRA, the Employee Retirement Income Security Act of 1974, the New Jersey Law Against Discrimination (as any of these laws may have been amended) or any other similar labor, employment or anti-discrimination laws; 

  

	 	e.	based on any contract, tort, whistleblower, personal injury, or wrongful discharge theory; and 

  

	 	f.	based on any other federal, state or local constitution, regulation, law (statutory or common), or legal theory. 

  
 7. EMPLOYEE’s Covenant Not to Sue or Accept Recovery; No Prior Assignment

  
 EMPLOYEE covenants not to sue RELIANT or any RELEASEES on account of any
claim released hereby. EMPLOYEE further covenants not to accept, recover or receive any monetary damages or any other form of relief which may arise out of or in connection with any administrative remedies which may be filed with or pursued
independently by any governmental agency or agencies, whether federal, state or local. EMPLOYEE represents and warrants that he has not assigned or transferred, in any manner, including by subrogation or operation of law, any portion of any claim,
action, complaint, charge or suit encompassed by the releases set forth in this Agreement. 
  

					
	Initials:         	 	4	 	Initials:         

 8. On The Job Illness or Injury At The Time of Execution 
  
 EMPLOYEE has no knowledge or claim of any condition, symptom or events that could give rise
to or be the result of any on the job illness or injury. 
  
 9. Return of
Property 
  
 EMPLOYEE agrees that he has not removed any RELIANT property
from RELIANT’s premises, except as authorized by RELIANT in writing, or that EMPLOYEE will return all of RELIANT’s property immediately upon execution of this Agreement. Such property includes, but is not limited to, the original and any
copies of any confidential information or trade secrets, all RELIANT-issued vehicles, computers, PDA’s keys, pass cards, customer lists, files, brochures, documents or computer disks or printouts, equipment and any other item relating to
RELIANT and its business. Further, EMPLOYEE agrees that he has not taken, procured, or copied any property of RELIANT on or after the Termination Date. 
  
 10. Cooperation in Legal Matters 
  
 In consideration for the promises and payments by RELIANT pursuant to this Agreement, EMPLOYEE agrees to cooperate to the fullest extent possible in the preparation,
defense or prosecution of any legal matters involving RELEASEES about which EMPLOYEE has or may have personal knowledge (other than EMPLOYEE termination or any other claim he may bring against RELEASEES), including any such matters which may be
filed after the termination of EMPLOYEE employment. 
  
 11. Cooperation in
Professional Transition of Business Affairs 
  
 In consideration for the
promises and payments by RELIANT pursuant to this Agreement, EMPLOYEE agrees to cooperate to the fullest extent possible in the professional transition of those business-related matters for which he was responsible during EMPLOYEE’s employment
with RELIANT. 
  
 12. No Interest in Reinstatement 
  
 EMPLOYEE hereby acknowledges that EMPLOYEE has no interest in reinstatement, reemployment or
employment with RELIANT, and EMPLOYEE forever waives any interest in or claim of right to any future employment by RELIANT. EMPLOYEE further covenants not to apply for future employment with RELIANT. 
  
 13. Confidentiality Regarding This Agreement 
  
 Except as otherwise expressly provided in this Section 13, the parties agree that the terms
and conditions of this Agreement are and shall be deemed to be confidential and hereafter shall not be disclosed to any other person or entity. The only disclosures excepted by this Section 13 are 

  

					
	Initials:         	 	5	 	Initials:         

 
(a) as may be required by law; (b) the parties may tell prospective employers the dates of EMPLOYEE’s employment, positions held, evaluations received,
EMPLOYEE’s duties and responsibilities and salary history with RELIANT; (c) the parties may disclose the terms and conditions of this Agreement to their attorneys, accountants and/or tax advisors; (d) RELIANT may disclose this Agreement, its
terms and conditions to financing sources, investment bankers, advisors to such persons and in connection with an organic transaction; provided that the receiving party is subject to an obligation of confidentiality to RELIANT and (e) the parties
may disclose the terms and conditions of this Agreement to their respective spouses, if any, provided, however, that EMPLOYEE makes EMPLOYEE’s spouse aware of the confidentiality provisions of this paragraph and EMPLOYEE’s spouse agrees to
keep the terms of this Agreement confidential. 
  
 14. Resignations

  
 EMPLOYEE hereby resigns as an officer and director of RELIANT, each of
its subsidiaries and any committees of the boards of directors of RELIANT and each of its subsidiaries. 
  
 15. Assignment 
  
 This Agreement
shall be binding upon EMPLOYEE and shall not be subject to assignment or delegation by EMPLOYEE without RELIANT’s express written consent. This Agreement shall likewise be binding upon RELIANT and its successors and assigns, and shall be
subject to assignment by RELIANT, without EMPLOYEE’S consent, (a) to any affiliate of RELIANT or (b) to any third-party in connection with (i) the sale of all or substantially all of the assets of RELIANT or (ii) a merger, consolidation or
similar transaction involving RELIANT. This Agreement shall inure to the benefit of and be enforceable by the parties hereto, and their respective heirs, personal representatives, successors and assigns. 
  
 16. Severability 
  
 If any provision of this Agreement is held to be invalid, illegal or unenforceable, such provision shall be severed and enforced to the
extent possible or modified in such a way as to make it enforceable, and the invalidity, illegality or unenforceability thereof shall not affect the validity, legality or enforceability of the remaining provisions of this Agreement; provided,
however, that both parties acknowledge and agree that the general release contained in Section 6, and the covenants in Sections 7 and 24 hereof are essential terms of this Agreement. If any of Section 6 or Sections 7 and 24 is held to be
unenforceable by an arbitrator pursuant to Section 22 or a court of competent jurisdiction, the remaining provisions of this Agreement shall be enforceable at RELIANT’s sole discretion. 
  

					
	Initials:         	 	6	 	Initials:         

 17. Governing Law 
  

This Agreement shall be governed by and interpreted and construed in accordance with the laws of the State of New Jersey without reference to its internal conflict of
law principles. 
  
 18. Expenses 
  
 Each of RELIANT and EMPLOYEE shall bear its/his own costs and expenses in connection with
the negotiation and documentation of this Agreement. 
  
 19.
Counterparts 
  
 This Agreement may be executed in counterparts, each
of which shall be an original, but all of which shall constitute one and the same instrument. 
  
 20. Jurisdiction and Venue 
  
 The
parties irrevocably agree that all actions to enforce an arbitrator’s decision pursuant to Section 22 of this Agreement may be instituted and litigated in federal, state or local courts sitting in Newark, New Jersey and each of such parties
hereby consents to the jurisdiction and venue of such court, waives any objected based on forum non conveniens and any right to a jury trial as set forth in Section 21 of this Agreement. 
  
 21. Waiver of Jury Trial 
  
 EMPLOYEE hereby waives, releases and relinquishes and all rights he may have to a trial by
jury with respect to any actions arising directly or indirectly as a result or in consequence of this Agreement, including, without limitations, any claim or action to remedy any breach or alleged breach hereof, to enforce any term hereof, or in
connection with any right, benefit or obligation accorded or imposed by this Agreement. 
  
 22. Arbitration 
  
 Notwithstanding anything herein to the
contrary, in the event that there shall be a dispute among the parties arising out of or relating to this Agreement, or the breach thereof, the parties agree that such dispute shall be resolved by final and binding arbitration in Newark, New Jersey,
administered by the American Arbitration Association (the “AAA”), in accordance with the New Jersey Alternative Procedure for Dispute Resolution Act, AAA’s Commercial Arbitration Rules and the Federal Rules of Civil Procedure
relating to the production of evidence. The parties agree that the arbitrator may impose sanctions in his or her discretion to enforce compliance with discovery and other obligations. Such arbitration shall be presided over by a single arbitrator.
If EMPLOYEE, on the one hand, and RELIANT, on the other hand, do not agree on the arbitrator within fifteen (15) days after a party requests arbitration, the arbitrator shall be selected by 

  

					
	Initials:         	 	7	 	Initials:         

 
RELIANT and employee from a list of five (5) potential arbitrators provided by AAA. Such list shall be provided within ten (10) days of the request of any
party for arbitration. The party requesting arbitration shall delete one name from the list. The other party shall delete one name from the list. This process shall then be repeated in the same order, and the last remaining person on the list shall
be the arbitrator. This selection process shall take place within the two (2) business days following both parties’ receipt of the list of five (5) potential arbitrators. Hearings in the arbitration proceedings shall commence within twenty (20)
days of the selection of the arbitrator or as soon thereafter as the arbitrator is available. The arbitrator shall deliver his or her opinion within twenty (20) days after the completion of the arbitration hearings. The arbitrator’s decision
shall be final and binding upon the parties, and may be entered and enforced in any court of competent jurisdiction by either of the parties. The arbitrator shall have the power to grant temporary, preliminary and permanent relief, including without
limitation, injunctive relief and specific performance. Unless otherwise ordered by the arbitrator pursuant to this Agreement, the arbitrator’s fees and expenses shall be shared equally by the parties. 
  
 23. No Reliance Upon Other Statements 
  
 This Agreement is entered into without reliance upon any statement or representation of any
party hereto or parties hereby released other than the statements and representations contained in writing in this Agreement. 
  
 24. Survival of Certain Covenants in the Employment Agreement 
  
 The parties recognize that certain terms of the Employment Agreement, dated September 1, 2000 (the “Employment Agreement”), are intended to survive
EMPLOYEE’S termination, including, but not limited to Section 6 (Termination Obligations), Section 7 (Records and Confidential Data), Section 8 (Assignment of Inventions), and all subsections of Section 9 (Covenants Not to Compete) other than
subsections (a) and (b). For purposes of clarification, and not limitation, subsections (c) (No Diversion) and (d) (Non-Recruitment) of Section 9 survive the termination of the Employment Agreement. To the extent that any conflicts may arise between
this Agreement and the surviving sections of the Employment Agreement, this Agreement shall be deemed controlling. 
  
 25. Entire Understanding 
  
 The parties acknowledge that this Agreement contains the entire understanding of the parties and that it may not be modified without the express written consent of the
parties hereto. 
  
 26. No Waiver 
  
 Any failure by any party to enforce any of their rights and privileges under this Agreement
shall not be deemed to constitute waiver of any rights and privileges contained herein. 
  

					
	Initials:         	 	8	 	Initials:         

 27. Full and Knowing Waiver 
  
 By signing this Agreement, EMPLOYEE certifies that: 
  

	 	a.	EMPLOYEE carefully read and fully understands the provisions of this Agreement; 

  

	 	b.	EMPLOYEE was advised by RELIANT in writing, via this Agreement, to consult with an attorney before signing this Agreement; 

  

	 	c.	RELIANT allows EMPLOYEE twenty-one (21) days from its initial presentation to EMPLOYEE to consider this Agreement before signing it; and, 

  

	 	d.	EMPLOYEE agrees to its terms knowingly, voluntarily and without intimidation, coercion or pressure. 

  
 28. Revocation of Agreement 
  
 EMPLOYEE may revoke this Agreement within seven (7) calendar days after signing it. To be effective, such revocation must be received in writing by Dr. Ernest Mario
personally at RELIANT Pharmaceutical, Inc., 110 Allen Road Liberty Corner, New Jersey 07938. Revocation can be made by hand delivery, telegram, facsimile, or postmarking before the expiration of this seven (7) days period. None of the obligations of
RELIANT under this Agreement shall be effective in the event that EMPLOYEE revokes this Agreement pursuant to this Section 28. 
  
 [Signature Page Follows] 
  

					
	Initials:         	 	9	 	Initials:         

 IN WITNESS WHEREOF the undersigned hereunto set their hands to this Agreement on the dates written below.

  

					
	 Keith Rotenberg
 (“EMPLOYEE”)
	 	 Reliant Pharmaceutical, Inc.
 (“RELIANT”)

			
	 /s/ Keith Rotenberg

	 	By:	 	 /s/ Joseph Zakrzewski

		
	 March 30, 2005
 Date
	 	 Joseph Zakrzewski

	 	Name
		
	 	 	 COO

	 	 	Title
		
	 	 	 March 30, 2005

	 	 	Date

  

					
	Initials:         	 	10	 	Initials:         

 EXHIBIT A 
 FIRST AMENDMENT TO 
 SECURED PROMISSORY NOTE 
  
 This First Amendment to Secured Promissory Note (the
“Amendment”) dated as of March     , 2005 is entered into between Keith Rotenberg (the “Maker”) and Reliant Pharmaceuticals, Inc., a Delaware company (as successor to Reliant
Pharmaceuticals, LLC) or its assignee (the “Payee”). 
  
 WITNESSETH: 
  
 WHEREAS, the Maker and the Payee
entered into a Secured Promissory Note dated February 28, 2001 (the “Note”) in the original principal amount of $200,000; and 
  
 WHEREAS, the Maker and the Payee wish to amend the Note in the manner set forth herein to modify the maturity of the Note. 
  
 NOW THEREFORE, in exchange for the agreements set forth herein, and good and
valuable consideration the receipt and sufficiency of which are hereby acknowledged, the Maker and the Payee hereby amend Section 4(a) of the Note effective by deleting the text thereof in its entirety, and substituting the following in lieu
thereof: 
  
 (a)
Principal; Interest and Enforcement Costs. Subject to Sections 5(b) and 7 below, (i) the outstanding principal amount of this Note, (ii) all accrued and unpaid interest thereon and (iii) all of Payee’s costs and expenses (including
reasonable fees and expenses of Payee’s attorneys, accountants and other professional commitments) of enforcing this Note (“Enforcement Costs”), shall be due and payable in full on the earliest to
occur of (A) February 28, 2006 or (B) any acceleration of the Obligations pursuant to Sections 6 and 7 below (each such event, the “Maturity”). All amounts due under this Note, including, without
limitation, principal, interest and Enforcement Costs are collectively referred to herein as the “Obligations”. 
  
 IN WITNESS WHEREOF, Maker and Payee have executed this First Amendment as of the day and year first above written.

  

					
	 	 	RELIANT PHARMACEUTICALS, INC.
			
	 /s/ Keith Rotenberg

	 	By:	 	 /s/ Joseph Zakrzewski

	Keith Rotenberg	 	Title:	 	COO
		
	Address:	 	Address:
	  

	 	 110 Allen Road
 Liberty Corner, NJ
07938

	  

	 	 

  

					
	Initials:         	 	11	 	Initials:Secured Promissory Note made by Keith S. Rotenberg

 Exhibit 10.19 
  
 SECURED PROMISSORY NOTE 
  

			
	$200,000	 	February 28, 2001
	 	 	Bridgewater, New Jersey

  
 1. Principal
Amount. For value received, the undersigned (“Maker”), does hereby promise to pay to the order of Reliant Pharmaceuticals, LLC, a Delaware limited liability company, or its assignee (“Payee”), the principal sum
of Two Hundred Thousand Dollars ($200,000) (the “Loan”), upon the terms and conditions set forth herein. 
  
 2. Interest. 
  
 (a) Accrual of Interest. Interest shall accrue on the unpaid principal of this promissory note (the “Note”) from
the date hereof until all amounts due hereunder are paid in full at a fluctuating interest rate per annum equal to the Prime Rate, compounded annually. “Prime Rate” shall mean the rate of interest announced by Bank One, N.A. (or its
successors) from time to time as its “Prime Rate.” Interest hereon shall be calculated on the basis of the actual number of days elapsed and a year of 365 days. Payments of interest on the unpaid principal hereof shall be due and payable
pursuant to Sections 3 or 4 hereof, as appropriate. 
  
 (b) No Usury. It is the intention of Maker and Payee to conform to applicable usury laws, if any. Accordingly, notwithstanding anything to the contrary in this Note or any other agreement entered into in connection herewith, it is
agreed as follows: (i) the aggregate of all interest and any other charges constituting interest under applicable law and contracted for, chargeable, or receivable under this Note or otherwise in connection with the obligation evidenced hereby shall
under no circumstances exceed the maximum amount of interest permitted by applicable law, if any, and any excess shall be deemed a mistake and cancelled automatically and, if theretofore paid, shall, at the option of Maker, be refunded to Maker or
credited on the principal amount of this Note; and (ii) in the event that the entire unpaid balance of this Note is declared due and payable by Payee, then earned interest may never include more than the maximum amount permitted by applicable law,
if any, and any unearned interest shall be cancelled automatically and, if theretofore paid, shall at the option of Maker, either be refunded to Maker or credited, to the extent permitted by law, on the principal amount of this Note. 
  
 3. Post-Maturity Interest. Any amount of principal and/or interest
hereon which is not paid when due, whether at stated maturity, by acceleration or otherwise, shall bear interest from the date when due until said principal and/or interest amount is paid in full, at the lesser of (a) an interest rate equal to two
percent (2%) per annum in excess of the interest rate set forth in Section 2(a) hereof and (b) the highest rate of interest allowable under applicable law. 

 4. Payments. 
  
 (a) Principal; Interest and Enforcement Costs. Subject to Sections 5(b) and 7 below, (i) the
outstanding principal amount of this Note, (ii) all accrued and unpaid interest thereon and (iii) all of Payee’s costs and expenses (including reasonable fees and expenses of Payee’s attorneys, accountants and other professional
commitments) of enforcing this Note (“Enforcement Costs”), shall be due and payable in full on the earliest to occur of (A) the fifth anniversary of the date hereof, (B) any acceleration of the Obligations pursuant to Section 7
below, (C) 90 days following the termination of Maker’s employment with Reliant Pharmaceuticals, LLC (the “Company”) (I) by the Company without Cause (as defined in the Company’s Equity Incentive Plan), (II) by the Maker
for good reason (as determined by the Compensation Committee of the Board of Managers of the Company), or (III) upon the death or Disability (as defined in the Company’s Equity Incentive Plan) of the Maker and (D) the termination of
Maker’s employment with the Company for any reason other than as set forth in clause (C) of this Section (each such event, the “Maturity”). All amounts due under this Note, including, without limitation, principal, interest and
Enforcement Costs are collectively referred to herein as the “Obligations”. 
  
 (b) Making of Payments. All payments of the Obligations in respect of this Note shall be made by delivery of a certified or bank
cashier’s check or of other immediately available funds and delivered to Payee on the date or dates due at the address of Payee set forth on the signature page hereof, or at such other place as the holder hereof may from time to time designate
in writing. Whenever any payment on this Note shall be stated to be due on a day which is not a Business Day (as defined below), such payment shall be made on the next succeeding Business Day and such extension of time shall be included in the
computation of the payment of interest on this Note. For purposes of this Note, “Business Day” means each day other than a Saturday, a Sunday or any other day on which banking institutions in Newark, New Jersey are authorized or
obligated by law or executive order to be closed. 
  
 5.
Prepayment. 
  
 (a) Voluntary
Prepayment. Maker, without premium or penalty, may prepay the Obligations in whole or in part upon three (3) Business Days’ prior written notice to Payee. 
  
 (b) Mandatory Prepayment. Maker shall promptly prepay the Obligations (i) with 100% of the proceeds
of any transfer, sale, disposition, pledge, hypothecation or encumbrance (a “Transfer”) of all or any portion of Maker’s equity interest in the Company (whether owned directly or indirectly), (ii) to the extent of all after-tax
proceeds of any distribution received by Maker in respect of or on account of Maker’s equity interest in the Company (whether owned directly or indirectly), exclusive of distributions made expressly to pay income taxes of Maker with respect to
Maker’s investment in the Company and (iii) to the extent of 50% of after-tax proceeds of any 

  

 2 

 
bonus payments made by the Company or its subsidiaries to Maker. To the extent practicable, Maker hereby instructs the Company to pay over all amounts
subject to mandatory prepayment under this Section 5(b) directly to the Payee, and such payments shall be deemed to have been made to the Maker by the Company and then paid by Maker to Payee. 
  
 (c) Application of Prepayment Proceeds. All proceeds
of any prepayments made pursuant to this Section 5 shall be applied first to the payment of Enforcement Costs, second to the payment of accrued but unpaid interest hereon and third to the payment of the outstanding principal balance of this Note.

  
 6. Events of Default. The occurrence of any one or more
of the following events shall constitute an “Event of Default” under this Note: 
  
 (a) Principal Payment Default. Maker shall fail to pay the outstanding principal amount due hereunder, or any portion thereof
within (5) days of when due, whether at Maturity, at such earlier date as is required by Sections 5(b) and/or 7, or otherwise; 
  
 (b) Interest and Enforcement Cost Payment Default. Maker shall fail to pay any interest which has accrued hereunder or any
Enforcement Costs within (5) days of when due; 
  
 (c) Dissolution; Termination. The dissolution, termination and/or liquidation of the Company; 
  
 (d) Covenant Default. Maker shall default in the observance or performance of any covenant or agreement contained in this Note
(other than those set forth in Sections 6(a), 6(b), 6(c), 6(e), 6(f), 6(g) and 6(h)) and such default shall not of its nature be curable by Maker, or if such default shall be curable, such default shall continue uncured for a period of ten (10) days
after receipt by Maker of written notice from Payee to such effect; 
  
 (e) Bankruptcy, etc. Maker becomes insolvent or generally fails to pay, or admits in writing his inability or refusal to pay, his debts as they become due; or Maker’s application for, consent to or
acquiescence in, the appointment of a trustee in bankruptcy, receiver or other custodian for Maker or any of his property or assets, or Maker’s making a general assignment for the benefit of his creditors; or, in the absence of such
application, consent or acquiescence, a trustee, receiver or other custodian is appointed for Maker or for a substantial part of his property or assets and such appointment is not discharged within 60 days thereafter; or any bankruptcy,
reorganization, debt arrangement or other case or proceeding under any bankruptcy or insolvency law, or any liquidation proceeding is commenced in respect of Maker and, if such case or proceeding is not commenced by Maker, it is either (i) consented
to or acquiesced in by Maker, or (ii) remains undismissed for 60 days; 
  

 3 

 (f) Default under Other Obligations to the Company. Maker defaults on any
obligations of Maker to the Company (or its subsidiaries) under any agreements between the Company (and/or its subsidiaries) and the Maker relating to Maker’s employment or engagement by the Company (and/or its subsidiaries), including without
limitation, the Company’s Equity Incentive Plan, which default has not been cured during any applicable cure period provided in such agreements; 
  
 (g) Default under Collateral Assignment. Maker defaults under the Collateral Assignment dated as of the date hereof (the
“Collateral Assignment”) made by the Maker in favor of the Payee; 
  
 (h) Use of Proceeds. Use of the proceeds of the Loan for any purpose other than payment of the exercise price upon the “early
exercise” of Maker’s options to acquire Class One Common limited liability company units from the Company; 
  
 7. Remedies. Upon or at any time after the occurrence of an Event of Default specified in Sections 6(a), 6(b), 6(c), 6(d), 6(f), 6(g) or 6(h)
hereof, the Obligations shall, at the option of Payee, become due and payable without presentment, demand, protest, notice of acceleration, notice of intent to accelerate or other notice of any kind, all of which are hereby expressly waived by
Maker, anything in this Note to the contrary notwithstanding. Upon the occurrence of an Event of Default specified in Section 6(e) hereof, the Obligations shall thereupon and concurrently therewith become due and payable. The Maker and every
endorser or guarantor hereof agrees, subject only to any limitation imposed by law, to pay on demand all expenses, including reasonable attorneys’ fees, disbursements and legal expenses, incurred by the holder of this Note in endeavoring to
collect any amounts payable hereunder which are not paid when due, whether by acceleration or otherwise, in addition to any other remedy available in law or equity. 
  
 8. Waivers. Maker and every endorser and guarantor of this Note hereby jointly and severally waives presentment,
demand, notice, protest and all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement hereof that no such extension or other indulgence, and no substitution, release or surrender of collateral,
and no discharge or release of any other party primarily or secondarily liable hereof, shall discharge or otherwise affect the liability of Maker. No delay or omission on the part of holder in exercising any right hereunder shall operate as a waiver
of any such right, and the waiver of any such right on any one occasion shall not be construed as a bar to or waiver of any such right on any future occasion. 
  

9. Security. This Note is secured by Maker’s equity interests in the Company pursuant to the Collateral Assignment. 
  
 10. Transfer of Note. Until notified by Payee in writing of the
transfer of this Note, Maker shall be entitled to deem Payee or such person who has been so identified by Payee in writing to Maker as the owner and holder of this Note. 
  

 4 

 11. Notices. Every notice or other communication required or desired to be given hereunder shall
be in writing and shall be delivered either by personal delivery, telegram, a nationally recognized courier service, postage-prepaid certified or registered mail, return receipt requested, or facsimile transmission with acknowledgment of receipt,
addressed to the party to whom intended at the address set forth on the signature page attached to this Note or at such other address as the intended recipient previously shall have designated by written notice. Notice by courier or certified or
registered mail shall be effective on the date it is officially recorded as delivered to the intended recipient by return receipt or similar acknowledgment, or the date of attempted delivery where delivery is refused by the intended recipient. All
notices and communications delivered in person shall be deemed to have been delivered to and received by the addressee, and shall be effective, on the date of personal delivery. Any notice transmitted by telegram or facsimile transmission shall be
deemed to have been delivered to and received by the addressee, and shall be effective, on the date said notice is delivered to the telegram company for transmission or received by the recipient, respectively. 
  
 12. Governing Law. This Note shall be governed and construed and the
rights and liabilities of the parties hereto shall be determined in accordance with the internal laws of the State of New Jersey, without regard to the conflict of laws principles thereof. 
  
 13. Jurisdiction; Service of Process. Maker hereby submits to the
nonexclusive jurisdiction of the United States Federal and State of New Jersey courts for all purposes of or in connection with this Agreement; provided that nothing in this Agreement shall affect Payee’s right to bring any action or proceeding
against Maker or Maker’s property in the courts of any other jurisdiction. Maker hereby consents to process being served in any suit, action or proceeding of the nature referred to above either (a) by the mailing of a copy thereof by registered
or certified mail, postage prepaid, return receipt requested, to its address shown below its signature hereto or (b) by serving a copy thereof upon Maker’s authorized agent for service of process (to the extent permitted by applicable law,
regardless whether the appointment of such agent for service of process for any reason shall prove to be ineffective or such agent for service of process shall accept or acknowledge such service); provided that, to the extent lawful and practicable,
written notice of said service upon said agent shall be mailed by registered or certified mail, postage prepaid, return receipt requested, to Maker at Maker’s address shown below its signature hereto. Maker agrees that such service, to the
fullest extent permitted by law, (i) shall be deemed in every respect effective service of process upon it in any such suit, action or proceeding and (ii) shall be taken and held to be valid personal service upon and personal delivery to Maker.
Nothing herein shall affect Payee’s right to serve process in any other manner permitted by law, or limit Payee’s right to bring proceedings against Maker in the courts of any other jurisdiction. 
  
 14. Waiver of Jury Trial. MAKER HEREBY IRREVOCABLY WAIVES ANY RIGHT
TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING (I) TO ENFORCE OR DEFEND ANY RIGHTS UNDER OR IN CONNECTION WITH THIS NOTE OR ANY AMENDMENT, INSTRUMENT, DOCUMENT OR AGREEMENT DELIVERED OR WHICH MAY IN THE FUTURE BE DELIVERED IN CONNECTION HEREWITH, OR
(II) ARISING FROM ANY DISPUTE OR CONTROVERSY IN CONNECTION WITH OR RELATED TO THIS NOTE, AND AGREES THAT ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. 
  

 5 

 15. Recourse. Maker acknowledges that the obligations of Maker to Payee under or in connection
with this Note are recourse to Maker as to 100% of the accrued interest hereon and 50% of any principal balance. For the purposes of clarification and not in limitation of Payees rights hereunder, in the event that Maker fails to pay all the
obligations hereunder when due and, the value of the collateral under the Collateral Assignment does not fully defease Maker’s obligations hereunder, Payee shall have recourse to Maker’s assets (in addition to the assets assigned pursuant
to the Collateral Assignment) to the extent of any deficiency up to 100% of any accrued interest and 50% of the Loan. 
  
 16. Assignment. This Note and all rights and remedies hereunder shall be fully assignable by Payee and, following such assignment, any such
assignee shall be deemed the “Payee” for all purposes hereunder. Neither this Note nor any obligations or duties hereunder may be sold, assigned or delegated by the Maker without the prior written consent of the Payee. 
  
 17. Distribution Instructions. Maker hereby instructs Payee to make
payment of all amounts borrowed hereunder by Maker directly to the Company in payment of the exercise price upon the “early exercise” of Maker’s options to acquire Class One Common limited liability company units from the
Company. 
  
 [REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK] 
  

 6 

 IN WITNESS WHEREOF, Maker has executed and delivered this Note as of the day and year first above
written. 
  

	
	MAKER:
	
	  

	Keith Rotenberg
	
	Address:
	  

	  

	  

  

	
	PAYEE’S ADDRESS:
	
	Reliant Pharmaceuticals, LLC
	721 Route 202/206 South
	Mack/Cali Building, 1st Floor
	Bridgewater, New Jersey 08807
	Attention: Chief Financial Officer
	Telecopy No.: 908/526-5521

  
 [SIGNATURE PAGE TO
SECURED PROMISSORY NOTE IN FAVOR OF RELIANT 
 PHARMACEUTICALS, LLC] 
  

 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]